Imaging Studies and the Development of Multiple Myeloma
|2||Active, not recruiting||
Carfilzomib, Lenalidomide, and Dexamethasone in New Multiple Myeloma Patients
Imaging in MGUS, SMM and MM
QUIREDEX: Revlimid (Lenalidomide) and Dexamethasone (ReDex) Treatment Versus Observation in Patients With Smoldering Multiple Myeloma With High Risk of Progression
GEM05 for Patients With Multiple Myeloma Under 65 Years
GEM05 for Patients With Multiple Myeloma More Than 65 Years Old
† Study has passed its completion date and status has not been verified in more than two years.